Literature DB >> 11331490

Toxoplasmosis in a group of glucose-6-phosphate dehydrogenase deficient patients.

K F Tabbara1, N A Sharara, A K Al-Momen.   

Abstract

OBJECTIVE: This was a retrospective study that aimed at evaluating the relative risk of Toxoplasma infection in patients with glucose-6-phosphate dehydrogenase deficiency as compared to a control group with no glucose-6-phosphate dehydrogenase deficiency.
METHODS: Ninety-one blood donor volunteers had serology testing from Toxoplasma gondii and were screened for glucose-6-phosphate dehydrogenase deficiency by a qualitative method using fluorescent spot test. They were all males and their ages ranged from 17 to 52 years.
RESULTS: Fifty-three persons (58%) were glucose-6-phosphate dehydrogenase deficient and 38 (42%) were glucose-6-phosphate dehydrogenase normal. In the glucose-6-phosphate dehydrogenase deficient group, 31 (58.5%) had positive titers for Toxoplasma; while in the glucose-6-phosphate dehydrogenase normal group 9 persons (24%) had positive titers for Toxoplasma. The relative risk of infection was 2.5 times more in the glucose-6-phosphate dehydrogenase deficient group, a statistically significant difference with a p value of 0.002.
CONCLUSION: Glucose-6-phosphate dehydrogenase deficiency seems to increase the risk for Toxoplasma infection by 2.5 fold probably due to decreased killing effect, of phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331490

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  2 in total

1.  Patient with toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency: a case report.

Authors:  Altacílio A Nunes
Journal:  Cases J       Date:  2009-08-06

2.  Is there a need for neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Canada?

Authors:  Aaron Leong
Journal:  Mcgill J Med       Date:  2007-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.